Study of Controlled Human Plasmodium Vivax Infection

NACompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

March 3, 2018

Primary Completion Date

April 13, 2023

Study Completion Date

April 13, 2023

Conditions
Malaria, Vivax
Interventions
OTHER

Plasmodium vivax infection

Two healthy human volunteers are exposed to the bites of five infectious mosquitoes per participant (by placing their forearms over the pot containing mosquitoes) for 5-10 minutes. Fed mosquitoes (as indicated by the presence of a blood meal in the abdomen) are individually dissected and assessed for sporozoite load (graded 0 to +4; a gland rating of +2 or more, representing 10 or more observed sporozoites, qualifies as being infectious). If, by this method the volunteer is found to have been inoculated by less than five infected mosquitoes, further mosquitoes are allowed to feed on the volunteer until a total of 5 appropriately infected mosquitoes have fed. The bite-challenge procedure continues until the subject has been bitten by 5 infectious mosquitoes.

PROCEDURE

Collection of 250mL blood from each volunteer (N=2)

Collection of 250mL of P. vivax-infected blood from each volunteer when a threshold parasitaemia/ symptoms are met

Trial Locations (2)

OX3 7LE

Centre for Clinical Vaccinology & Tropical Medicine, Oxford

John Warin Ward, Oxford University NHS Foundation Trust, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER

NCT03377296 - Study of Controlled Human Plasmodium Vivax Infection | Biotech Hunter | Biotech Hunter